Lv1
54 积分 2024-11-22 加入
Relocalizing transcriptional kinases to activate apoptosis
21小时前
待确认
Strategic Design of Triple GLP-1R/GCGR/GIPR Agonists with Varied Receptor Potency: Achieving Comparable Glycemic and Weight Reduction Effects
3天前
已完结
The preclinical discovery and development of zanubrutinib for the treatment of chronic lymphocytic leukemia
6天前
已完结
Broader horizons for cereblon glue degraders
2个月前
已关闭
Identification of KMH-45, a novel MRGPRX2 inhibitor with enhanced anti-pruritic properties
2个月前
已完结
Crystal Structure of Bimekizumab Fab Fragment in Complex with IL-17F Provides Molecular Basis for Dual IL-17A and IL-17F Inhibition
3个月前
已完结
Remibrutinib in Chronic Spontaneous Urticaria
3个月前
已完结
Crystal Structure of Bimekizumab Fab Fragment in Complex with IL-17F Provides Molecular Basis for Dual IL-17A and IL-17F Inhibition
3个月前
已完结
Isoxazole-pyrimidine derivatives as TACC3 inhibitors: A novel modality to targeted cancer therapy
4个月前
已完结
Discovery of a potent anticancer agent against pancreatic ductal adenocarcinoma targeting FAK with DFG-out state and JAK/Aurora kinases
6个月前
已完结
皖公网安备34019202002308
